Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices 50655 

Incontinence 

Dyspareunia 

Castleman Disease 

Gestational Carrier 

Third Degree Laceration 

Ectopic Pregnancy 

Initial Encounter and Surveillance for 

vaginal ring 

hormonal contraceptive device and 

transdermal patch 

hormonal contraceptive device 

Ovarian Cyst Laterality 

Supervision of Pregnancy with History 

of Ectopic or Molar Pregnancy 

National Institute of Health Stroke Scale 

Irritable Bowel Syndrome 

Chronic Idiopathic Constipation 

ICD–10–CM Addendum 

Agenda items are subject to change as 

priorities dictate. 

Note: CMS and NCHS will no longer 

provide paper copies of handouts for the 

meeting. Electronic copies of all meeting 

materials will be posted on the CMS and 

NCHS Web sites prior to the meeting at 

http://www.cms.hhs.gov/

ICD9ProviderDiagnosticCodes/03_

meetings.asp#TopOfPage and http://

www.cdc.gov/nchs/icd/icd9cm_

maintenance.htm. 

Contact Persons for Additional 

Information: Donna Pickett, Medical 

Systems Administrator, Classifications 

and Public Health Data Standards Staff, 

NCHS, 3311 Toledo Road, Room 2413, 

Hyattsville, Maryland 20782, email 

dfp4@cdc.gov, telephone 301–458–4434 

(diagnosis); Mady Hue, Health 

Insurance Specialist, Division of Acute 

Care, CMS, 7500 Security Boulevard, 

Baltimore, Maryland 21244, email 

marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Gary Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–20067 Filed 8–22–14; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–1856 and CMS– 

1893, and CMS–10380] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by September 24, 

2014. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS Desk 

Officer, Fax Number: (202) 395–5806 

OR, Email: OIRA_submission@

omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: (CMS–1856) 

Request for Certification in the Medicare 

and/or Medicaid Program to Provide 

Outpatient Physical Therapy and/or 

Speech Pathology Services, and (CMS– 

1893) Outpatient Physical Therapy— 

Speech Pathology Survey Report; Use: 

Form CMS–1856 is used as an 

application to be completed by 

providers of outpatient physical therapy 

and/or speech-language pathology 

services requesting participation in the 

Medicare and Medicaid programs. This 

form initiates the process for obtaining 

a decision as to whether the conditions 

of participation are met as a provider of 

outpatient physical therapy, speechlanguage pathology services, or both. It 

is used by the State agencies to enter 

new providers into the Automated 

Survey Process Environment (ASPEN). 

Form CMS–1893 is used by the State 

survey agency to record data collected 

during an on-site survey of a provider of 

outpatient physical therapy and/or 

speech-language pathology services, to 

determine compliance with the 

applicable conditions of participation, 

and to report this information to the 

Federal government. The form is 


emcdonald on DSK67QTVN1PROD with NOTICES
50656 Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices 

primarily a coding worksheet designed 

to facilitate data reduction and retrieval 

into the ASPEN system. The 

information needed to make 

certification decisions is available to us 

only through the use of information 

abstracted from the form. 

Form Numbers: CMS–1856 and CMS– 

1893 (OMB control number: 0938– 

0065); Frequency: Annually, 

occasionally; Affected Public: Private 

sector—Business or other for-profit and 

Not-for-profit institutions; Number of 

Respondents: 700; Total Annual 

Responses: 700; Total Annual Hours: 

613. (For policy questions regarding this 

collection contact James Cowher at 410– 

786–1948.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Reporting 

Requirements for Grants to States for 

Rate Review Cycle I, Cycle II, Cycle III, 

and Cycle IV and Effective Rate Review 

Program; Use: Under the section 1003 of 

the Affordable Care Act (ACA) (section 

2794 of the Public Health Service Act), 

the Secretary, in conjunction with the 

states and territories, is required to 

establish a process for the annual 

review, beginning with the 2010 plan 

year, of unreasonable increases in 

premiums for health insurance 

coverage. Section 2794(c) requires the 

Secretary to establish the Rate Review 

Grant Program to states to assist states 

to implement this provision. In 

addition, section 2794(c) requires the 

Rate Review Grant Program to assist 

states in the establishment and 

enhancement of ‘‘Data Centers’’ that 

collect, analyze, and disseminate health 

care pricing data to the public. 

Concurrent with this information 

collection request (ICR), HHS released 

Cycle IV of the Rate Review Grants, 

‘‘Grants to States to Support Health 

Insurance Rate Review and Increase 

Transparency in the Pricing of Medical 

Services.’’ The purpose of Cycle IV of 

the Rate Review Grant Program is to 

continue the rate review successes of 

Cycles I, II, and III, as well as to provide 

greater support to Data Centers, thereby 

enhancing medical pricing 

transparency. States and territories that 

apply for funds are required to complete 

the grant application. States and 

territories that are awarded funds under 

this funding opportunity are required to 

provide the Secretary with rate review 

data, four quarterly reports, and one 

annual report per year until the end of 

the grant period detailing the state’s 

progression towards a more 

comprehensive and effective rate review 

process. A final report is due at the end 

of the grant period. This information 

collection is required for effective 

monitoring of grantees and to fulfill 

statutory requirements under section 

2794(b)(1)(A) of the ACA that requires 

grantees, as a condition of receiving a 

grant authorized under section 2794(c), 

to report to the Secretary information 

about premium increases. 

On May 23, 2011, CMS published a 

final rule with comment period (76 FR 

29964) to implement the annual review 

of unreasonable increases in premiums 

for health insurance coverage called for 

by section 2794. Under the regulation, if 

CMS determines that a state has an 

Effective Rate Review Program in a 

given market, using the criteria set forth 

in the rule, CMS will adopt that state’s 

determinations regarding whether rate 

increases in that market are 

unreasonable, provided that the state 

reports its final determinations to CMS 

and explains the bases of its 

determinations. The final rule titled 

‘‘Patient Protection and Affordable Care 

Act; Health Insurance Market Rules; 

Rate Review’’ (78 FR 13406; February 

27, 2013) amends the standards under 

the Effective Rate Review Program. 

Currently, CMS relies on publicly 

available information and annual calls 

with individual states to obtain the 

information needed to evaluate whether 

a state has begun to or continues to 

satisfy the Effective Rate Review 

Program criteria. CMS is proposing to 

instead collect the information in 

writing from all states that would like to 

request effective status. No comments 

were received in response to the 60-day 

Federal Register notice published on 

June 2, 2014 (79 FR 31336). Form 

Number: CMS–10380 (OMB control 

number: 0938–1121); Frequency: 

Annually and On occasion; Affected 

Public: Public Sector and State and 

Territory Governments; Number of 

Respondents: 50; Total Annual 

Responses: 553; Total Annual Hours: 

20,951. (For policy questions regarding 

this collection contact Susie Lorden at 

301–492–4162.) 

Dated: August 19, 2014. 

Martique Jones, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2014–20041 Filed 8–22–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0501] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Third Party 

Disclosure and Recordkeeping 

Requirements for Reportable Food 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by September 

24, 2014. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0643. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd.; COLE–14526, Silver 

Spring, MD 20993–0002 PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Third Party Disclosure and 

Recordkeeping Requirements for 

Reportable Food—21 U.S.C. 350f (OMB 

Control Number 0910–0643)—Extension 

The Federal Food, Drug, and Cosmetic 

Act (the FD&C Act), as amended by the 

Food and Drug Administration 

Amendments Act of 2007 (FDAAA) 

(Pub. L. 110–85) requires the 

establishment of a Reportable Food 

Registry (the Registry) by which 

instances of reportable food must be 

submitted to FDA by responsible parties 

and may be submitted by public health 

officials. Section 417 of the FD&C Act 

(21 U.S.C. 350f) defines ‘‘reportable 


emcdonald on DSK67QTVN1PROD with NOTICES